U.S. Health Care REITs Stock News

Morgan Stanley (NYSE:MS) is forecasting a sharp rise in global AI-related debt issuance as early as 2026. The firm expects AI-tied bond financing to more than double that year, driven by hyperscalers seeking new funding sources. These debt deals are linked to record capital investment plans for AI infrastructure that could surpass US$1t in 2027. Morgan Stanley is involved in advising on and arranging this funding, positioning the firm at the center of this financing trend. Morgan Stanley...

If you are wondering whether Stryker at around US$314 per share still offers value, it helps to separate the headline share price from what the underlying business may be worth. Over shorter periods the stock has been strong, with returns of 7.1% over the last week and 10.0% over the last month, but the year-to-date return has declined 9.8% and the 1-year return is down 17.7%. This may change how you think about both opportunity and risk. Recent coverage has focused on Stryker's position in...

Wondering if Samsara's current share price reflects its true worth, or if the recent swings are opening up a potential opportunity for you? The stock last closed at US$33.62 and has been volatile recently. It fell about 10% over the past week, rose 13% over the past month, and is still down 19.8% over the past year, with a 3 year return of 10.9% and a small year to date decline of 0.9%. These moves have kept Samsara on many investors' watchlists as they reassess how the stock fits into their...

Avanos Medical (AVNS) has recently attracted attention after a period of strong stock performance, with the share price up 87% over the past 3 months and 124% year to date. See our latest analysis for Avanos Medical. The recent rally appears concentrated in the past quarter, with a 90 day share price return of 86.79% and a 1 year total shareholder return of 93.88%. This contrasts with a 5 year total shareholder return that is down 37.38%, suggesting renewed momentum after a weaker longer term...

Exelixis (EXEL) is back in focus after new subgroup data from the phase 3 CABINET trial showed that CABOMETYX improved progression-free survival versus placebo in advanced neuroendocrine tumor patients across both non-functional and functional groups. See our latest analysis for Exelixis. The share price has moved to US$52.99 after a 26.92% 90 day share price return and a 24.62% 1 year total shareholder return, with momentum building alongside the CABINET data and recent conference and...

Walmart is expanding its Express Delivery service, with in app Subway ordering and delivery now rolling out across six US states. The company plans to reach about 1,400 stores by the end of summer, allowing customers to add Subway meals to regular Walmart orders. Walmart is positioning the service with transparent pricing and no hidden fees, and is exploring additional quick service restaurant partnerships. For investors watching NasdaqGS:WMT, this move comes with the stock trading around...

We wouldn't blame Cryoport, Inc. ( NASDAQ:CYRX ) shareholders if they were a little worried about the fact that Robert...

Over the last 7 days, the United States market has experienced a 3.3% decline, yet it remains up by 22% over the past year with anticipated earnings growth of 17% per annum in the coming years. In this dynamic environment, identifying small-cap stocks that are perceived as undervalued and exhibit insider activity can offer intriguing opportunities for investors seeking to navigate current market conditions.

Over the last 7 days, the United States market has dropped 3.3%, yet it remains up by 22% over the past year, with earnings expected to grow by 17% annually in the coming years. In this fluctuating environment, identifying stocks that may be trading at a discount can offer investors opportunities to capitalize on potential value gains.

Over the last 7 days, the United States market has experienced a 3.3% decline, yet it remains up by 22% over the past year with earnings anticipated to grow by 17% annually in the coming years. In this context, growth companies with substantial insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and potential.

Over the last 7 days, the United States market has dropped 3.3%, though it has risen by 22% over the past year, with earnings forecasted to grow annually by 17%. In light of these conditions, identifying stocks with robust financials and clear growth potential is crucial, especially when considering penny stocks—an older term that still signifies smaller or less-established companies offering unique opportunities. This article highlights three such penny stocks that stand out for their...

Over the last 7 days, the United States market has experienced a 3.3% drop, although it remains up by 22% over the past year with earnings forecasted to grow by 17% annually. In such fluctuating conditions, dividend stocks like Virginia National Bankshares can offer investors stability and income potential through regular payouts.

Anyone interested in Arko Corp. ( NASDAQ:ARKO ) should probably be aware that the General Counsel & Secretary, Maury...

Anyone interested in Hanmi Financial Corporation ( NASDAQ:HAFC ) should probably be aware that the Senior EVP & Chief...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see UnitedHealth...

The recent 15% drop in Greenpro Capital Corp.'s ( NASDAQ:GRNQ ) stock could come as a blow to insiders who purchased...

If you are wondering whether Watsco at around US$386 per share represents fair value or a potential opportunity, this article breaks down what the current price might be indicating. The stock has been mixed recently, with a 6.1% gain over the past week, a decline of 8.2% over the past month, an 11.2% gain year to date, and an 11.5% decline over the past year. Recent coverage of Watsco has focused on keeping investors informed with ongoing, evergreen analysis rather than reacting to a single...

If you are wondering whether Dynatrace is starting to look attractively priced, or if the recent share moves are a warning sign instead, this article walks through what the current price might be indicating. The stock last closed at US$40.77, with the share price roughly flat over 30 days (up 0.2%) but down 24.7% over the past year, which may have influenced how investors view its risk and return trade off. Recent coverage has focused on Dynatrace's positioning in observability and...

Synchrony Financial (NYSE:SYF) has been named the No. 1 Best Workplace in New York by Great Place To Work and Fortune magazine. The company is the first to hold the top workplace ranking in both New York and the U.S. at the same time. This recognition highlights Synchrony's focus on workplace culture, employee experience, and employer reputation. Synchrony Financial, a consumer financial services company listed on the NYSE as SYF, operates in areas such as private label credit cards,...

The Schall Law Firm has begun investigating Doximity, Inc. over potential securities law violations after the company’s May 13, 2026 results missed revenue expectations and highlighted near-term margin pressure from AI investments. This combination of weaker-than-anticipated performance and legal scrutiny raises fresh questions about how Doximity is communicating the financial impact of its AI roadmap to investors. We’ll now examine how concerns about margin pressure from AI spending could...

It's been a mediocre week for PVH Corp. ( NYSE:PVH ) shareholders, with the stock dropping 18% to US$79.92 in the week...

Blue Owl Capital (NYSE:OWL) has opened a new regional headquarters in Abu Dhabi’s ADGM, expanding its presence across the UAE and wider Middle East. The firm is advancing a planned US$2.4b acquisition of Sila Realty Trust, while facing related shareholder lawsuits. Blue Owl is also reviewing options for Stack Infrastructure’s Asia data center assets, including a possible sale. For investors, these updates show how Blue Owl is building out its global private markets footprint across credit,...

Recent share performance context HCA Healthcare (HCA) has drawn attention after a recent pullback, with the stock down about 14% over the past month and 30% over the past 3 months, despite a modest 1-year total return of 3%. See our latest analysis for HCA Healthcare. Short term, the stock has been under pressure, with the 30 day share price return down 13.85% and the 90 day share price return down 30.22%. At the same time, the 5 year total shareholder return of 86.19% reflects a much...

Earlier this month, Celanese Corporation shut down its Engineered Materials compounding facility in Ulsan, South Korea, shifting production to plants in Nanjing and Shenzhen, China, and Silvassa, India as part of its ‘Grow & Fortify’ production network optimization. In parallel, Aisan Industry Kentucky, LLC. adopted Celanese’s polyacetal resin made from captured CO2 for automotive fuel pump modules, highlighting growing traction for the company’s lower-carbon POM ECO-C solutions in...